Edition:
United States

Godavari Drugs Ltd (GDRU.BO)

GDRU.BO on Bombay Stock Exchange

36.10INR
21 Sep 2017
Change (% chg)

-- (--)
Prev Close
Rs36.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,365
52-wk High
Rs54.90
52-wk Low
Rs33.10

Chart for

About

Godavari Drugs Limited is engaged in the contract manufacturing, loan license manufacturing, manufacturing and supply of active pharmaceutical ingredients (APIs), drug intermediaries and fine chemicals. The Company's API products include Ciprofloxacin Hydrochloride, Enrofloxacin, Centrizine Hydrochloride and Ethambutol... (more)
No analyst recommendations are available for .

Overall

Beta: 2.19
Market Cap(Mil.): Rs269.22
Shares Outstanding(Mil.): 7.53
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.87 16.33
EPS (TTM): -- -- --
ROI: -- 15.11 14.66
ROE: -- 16.37 13.99

BRIEF-Godavari Drugs gets shareholders' nod for re-appointing Mukund Kakani as MD

* Gets shareholders' nod for re-appointment of Mukund Kakani as MD Source text - http://bit.ly/2wWHXRq Further company coverage:

Sep 12 2017

BRIEF-India's Godavari Drugs June qtr profit rises

* June quarter net profit 891,000 rupees versus profit of 440,000 rupees year ago

Sep 12 2017

Earnings vs. Estimates

No consensus analysis data available.